4 Stocks Pushing The Health Services Industry Downward

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 73 points (0.5%) at 14,495 as of Friday, March 22, 2013, 12:45 PM ET. The NYSE advances/declines ratio sits at 1,725 issues advancing vs. 1,132 declining with 170 unchanged.

The Health Services industry currently sits down 0.1% versus the S&P 500, which is up 0.6%. On the negative front, top decliners within the industry include Agilent Technologies ( A), down 1.3%, Express Scripts ( ESRX), down 0.9% and Thermo Fisher Scientific ( TMO), down 0.6%. Top gainers within the industry include Smith & Nephew ( SNN), up 1.9%, Fresenius Medical Care Corporation ( FMS), up 1.2% and Covidien ( COV), up 0.5%.

TheStreet Ratings group would like to highlight 4 stocks pushing the industry lower today:

4. Cigna ( CI) is one of the companies pushing the Health Services industry lower today. As of noon trading, Cigna is down $0.36 (-0.6%) to $61.38 on light volume Thus far, 486,761 shares of Cigna exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $61.31-$62.11 after having opened the day at $61.90 as compared to the previous trading day's close of $61.74.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $17.8 billion and is part of the health care sector. The company has a P/E ratio of 11.1, below the S&P 500 P/E ratio of 17.7. Shares are up 15.5% year to date as of the close of trading on Thursday. Currently there are 9 analysts that rate Cigna a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Cigna Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you liked this article you might like

Healthcare Management Stocks Look Too Pricey for Activists

The Stock That Crashed 25% Overnight Has a Lesson to Teach Us: Market Recon